Search

CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Industry

News and features about the latest developments in optics with a focus on industry

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Night vision eye drops

US biohackers have reportedly boosted the dim-light vision of a test subject enabling him to better identify objects in a darkened environment

Night vision eye drops
A group of biohackers in the US have been testing eye drops to help people see in the dark.

Body modification and biology enthusiasts, Science for the Masses, reportedly boosted the night vision of a test subject enabling him to better identify objects in a darkened environment, with no reported side effects.

The group was able to increase light amplification of the human retina using chlorin e6 (Ce6), which is used in photodynamic therapy for cancer – where the chemical is activated with localised light to activate it and kill cancer cells.

In an open access, non-peer reviewed paper, the group describes its attempts to boost dim light vision by mixing Ce6 with insulin, saline and dimethlysulfoxide (DMSO) as an eye drop preparation. A total of 150µl of the mixture was administered to each eye, before covering them with scleral lenses and sunglasses to avoid light exposure.

After a period of adjustment, the test subject was reportedly able to identify symbols and subjects in a darkened room better than four control subjects. By the following morning, the subject’s sight had returned to normal levels and was reported to have no side effects up to 20 days after the tests.

The group writes: “Given the current results and the previous body of work on the technique, it seems fair to say that this technique is successful in its claims for low light amplification in the human eye.”